Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. sars cov 2 insight research assay for sars cov 2
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Sars Cov 2 Insight Research Assay For Sars Cov 2 Articles & Analysis

224 news found

Precision Aerosol Therapy Through AI and flexiVent-Controlled Delivery

Precision Aerosol Therapy Through AI and flexiVent-Controlled Delivery

Yang, L., et al (2024) introduces LungVis 1.0, an AI-driven imaging platform integrating light sheet fluorescence microscopy (LSFM) and deep learning for mapping nanoparticle (NP) deposition across murine lungs. The research highlights the advantages of aerosol-based delivery methods over traditional liquid-based approaches, emphasizing the uniformity of NP deposition in distal alveolar ...

BySCIREQ - an emka TECHNOLOGIES Company


CEPI’s $3.6B Initiative with ExcellGene: Single Molecule for Global Defense in COVID Trials

CEPI’s $3.6B Initiative with ExcellGene: Single Molecule for Global Defense in COVID Trials

A delegation of CEPI (Coalition of Epidemic Preparedness and Innovation) was received by ExcellGene SA, the biotech service company in Monthey, on December 4th for a two day scientific discussion event. The meeting was held together with delegations from India (Bharat Biotech, Hyderabad, India) and Australia (University of Sydney, Prof. Jamie Triccas) which, together with ExcellGene, ...

ByExcellGene SA


Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

In vitro diagnostics (IVD) are tests done on samples such as blood or tissue for the purpose of detecting diseases or other conditions. To facilitate efforts on IVD research, the US-based chemical supplier Alfa Chemistry has recently introduced three IVD products for laboratory use, adding to its already diverse range of biological reagents. The biological reagents previously launched by Alfa ...

ByAlfa Chemistry


CD ComputaBio Launches Revolutionary Antibody De Novo Design Service Pioneering Precision Medicine with AI

CD ComputaBio Launches Revolutionary Antibody De Novo Design Service Pioneering Precision Medicine with AI

CD ComputaBio, a reputable computational service provider in the field of biology, has proudly announced the launch of its Antibody De Novo Design technology, marking a pivotal moment in the field of drug discovery and development. This service harnesses the power of AI to engineer antibodies with unmatched precision, paving the way for targeted therapies, personalized medicine, and cutting-edge ...

ByCD ComputaBio


Amerigo Scientific Adds Viral Transport Medium CDC Protocol to Its Distribution List

Amerigo Scientific Adds Viral Transport Medium CDC Protocol to Its Distribution List

Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, recently cooperates with Life Science Group to distribute the Viral Transport Medium CDC Protocol. This item is designed to aid researchers in their efforts to study the latest virus strains and improve their understanding of the physiology and life cycle of viruses. ...

ByAmerigo Scientific


Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials

Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials

Alfa Chemistry, known as a chemical supplier for various high-quality chemicals and materials for both academia and the industry, has recently extended its offering scope to vaccine related products, including but not limited to: vaccine excipients, nucleic acid delivery excipients, cell culture media and pharmaceutical packaging. “Always bearing in mind that what customers truly need is the top ...

ByAlfa Chemistry


Groundbreaking Possibility for Alertgy`s Non-Invasive Propriety Sensor for Detecting Covid-19

Groundbreaking Possibility for Alertgy`s Non-Invasive Propriety Sensor for Detecting Covid-19

The ongoing COVID-19 pandemic necessitates the need for robust and reliable detection methods to tackle the spread of the virus and to alleviate the severe socio-economic consequences of the disease. Alertgy has partnered with Florida Atlantic University’s (FAU) Immunology and Virology Department to execute a collaborative study on the diagnostic capabilities of Alertgy’s newly ...

ByAlertgy


(Viral) Vaccine Manufacturing

(Viral) Vaccine Manufacturing

It is well accepted that vaccination is one of the most effective ways to prevent diseases. A vaccine helps the body’s immune system to recognize and fight pathogens like bacteria or viruses, which then keeps humans safe from the diseases they cause. Vaccines protect against a range of diseases, including measles, polio, diphtheria, tetanus, meningitis, influenza and cancer. ...

ByNuvonis


CEPI partners with Japan’s NEC Group to develop artificial intelligence-designed broadly protective betacoronavirus vaccine

CEPI partners with Japan’s NEC Group to develop artificial intelligence-designed broadly protective betacoronavirus vaccine

April 8, 2022; OSLO, Norway/ TOKYO, Japan: CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation (NEC: TSE: 6701) today announced the latest funding award under its US$200m programme to advance the development of vaccines that provide broad protection against SARS-CoV-2 variants and other betacoronaviruses[1]. CEPI will provide seed funding of up to US$4.8m to NEC ...

ByNEC OncoImmunity AS 


BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study

Lumen Bioscience — a clinical stage biopharmaceutical company developing biologic drugs for highly prevalent diseases — announced today preliminary results from a Biomedical Advanced Research and Development Authority (BARDA)-supported effort to develop an intranasal formulation of its drug candidate, LMN-301. This drug, produced in spirulina, contains an antibody cocktail for ...

ByLumen Bioscience, Inc.


Anavasi Diagnostics Announces New Additions to Leadership Team

Anavasi Diagnostics Announces New Additions to Leadership Team

Anavasi Diagnostics ('Anavasi'), a medical technology company focused on the development of novel molecular diagnostic testing, recently announced the addition of a Chief Financial Officer, Chief Operating Officer and Chief Commercial Officer to its management roster. Scott Hales, Chief Financial Officer of Anavasi Diagnostics, has 30 years of financial, operational and strategic advisory ...

ByAnavasi Diagnostics


iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update

iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update

BRYAN, Texas and SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming® Manufacturing System, today announces preliminary unaudited financial results for the fiscal year ended June 30, 2022, and provides a corporate update. “We ...

ByIbio, Inc.


Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers

Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers

Target knockdown and safety results support continued clinical development Alnylam and Regeneron intend to initiate a Phase 2 study in late 2022 Detailed results to be presented at an upcoming medical congress CAMBRIDGE, Mass. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Sep. 15, 2022-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Regeneron Pharmaceuticals (Nasdaq: REGN) announced today ...

ByAlnylam Pharmaceuticals, Inc.


Congratulations! Reetoo COVID-19 Ag Self-Test kit obtained CE certification

Congratulations! Reetoo COVID-19 Ag Self-Test kit obtained CE certification

Recently, Reetoo SARS-CoV-2 Antigen Rapid Self-test Kit (Colloidal Gold) received CE certification accredited by CeCert Sp. z o.o. and completed clinical validation in Vitalabo Laboratoria Medyczne Sp. z o.o. according to the latest EU guidance MDCG 2021-21 Guidance on performance evaluation of SARS-CoV-2 in vitro diagnostic, which means this product gained official access to the EU market. ...

ByShenzhen Reetoo Biotechnology Co.,Ltd


Breaking News! Reetoo Monkeypox Virus Real Time PCR Kit

Breaking News! Reetoo Monkeypox Virus Real Time PCR Kit

According to the report of World Health Organization (WHO) on May 21, more than 120 confirmed or suspected cases of monkeypox, a rare viral disease seldom detected outside Africa, have been reported in at least 12 non-epidemic countries around the world, including more than 20 confirmed cases in Portugal, Spain and the UK. At present, there are no relevant death cases. There is evidence that ...

ByShenzhen Reetoo Biotechnology Co.,Ltd


Nature publication: Ondine’s therapy suppresses SARS2 in COVID-19 patients

Nature publication: Ondine’s therapy suppresses SARS2 in COVID-19 patients

The Toronto-based research reports a decrease of viral infectivity of 90% of SARS-CoV-2 patient samples using Ondine’s nasal antimicrobial photodynamic disinfection (aPDT), with 70% of patient samples completely inactivated from a single 5-minute treatment. The nose is the primary location for SARS-CoV-2 entry and it has a central role in transmission and disease severity. The Journal ...

ByOndine Biomedical Inc


AIVITA Biomedical Announces Publication of Phase 1 and Phase 2 Trial Results of its COVID-19 Vaccine Candidate

AIVITA Biomedical Announces Publication of Phase 1 and Phase 2 Trial Results of its COVID-19 Vaccine Candidate

IRVINE, Calif. – AUG. 29, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today announced the publication of safety and efficacy results from Phase 1 and Phase 2 clinical trials investigating its anti-SARS-CoV-2 vaccine candidate AV-COVID-19 that is made at point-of-care by third-party personnel. The results were published in the article ...

ByAIVITA Biomedical, Inc.


How the COVID-19 PCR Test Works

How the COVID-19 PCR Test Works

The COVID-19, pandemic amongst other changes in our lifestyle, has introduced us to new medical terms that we are not quite familiar with, such as the term PCR (polymerase chain reaction). As you may already know, PCR is a method to detect SARS-COV-2 virus, more specifically its nucleic acid. It is the “golden standard” of SARS-2 detection, as declared by the World Health Association ...

BymiDIAGNOSTICS


Network of Automated External Defibrillators in Poland before the SARS-CoV-2 Pandemic: An In-Depth Analysis

Network of Automated External Defibrillators in Poland before the SARS-CoV-2 Pandemic: An In-Depth Analysis

Introduction: Sudden cardiac arrest (SCA), which causes more than half of all cardiovascular related deaths, can be regarded as a common massive global public health problem. Analyzing out-of-hospital cardiac arrest (OHCA) cases, one of the key components is automatic external defibrillators (AEDs). Aim: The aim of this study was to analyze the use and distribution of AEDs in Polish public ...

ByIntelesens Ltd


Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022

Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022

Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical Care Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on developing cost-effective, rapid, ...

ByBluejay Diagnostics, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT